Articles Index

Abbott Developing Anti-TNF Drug Adalimumab (Humira)
Adalimumab (Humira) to be the first fully human anti-TNF therapy for rheumatoid arthritis.

Access To Therapy Initiated For Humira (Adalimumab)
Adalimumab (Humira) being made available to rheumatoid arthritis patients in need of other treatment options.